文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

具有部分脱乙酰水溶性壳聚糖的新型表面修饰的纳米结构脂质载体,用于高效眼部递药。

Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.

机构信息

School of Pharmacy, Shenyang Pharmaceutical University Shenyang, Liaoning Province 110016, People's Republic of China.

出版信息

J Pharm Sci. 2012 Mar;101(3):1040-9. doi: 10.1002/jps.22813. Epub 2011 Nov 18.


DOI:10.1002/jps.22813
PMID:22102480
Abstract

The objective of this study was to propose novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan (NLC-PDSC) as an efficient ocular delivery system to improve its transcorneal penetration and precorneal retention. PDSC with a deacetylation degree of around 50% was synthesized using an improved method. NLC loaded with flurbiprofen (FB) were prepared by melt emulsification method. They presented spherical morphology under both transmission electron microscope and scanning electron microscope. After coating with 0.15% (w/v) PDSC solution, the NLC showed a core-shell structure and a reversed zeta potential. The enhanced transcorneal penetration of the coated NLC was evaluated using isolated rabbit corneas, with significantly increased apparent permeability coefficient being 1.40- and 1.75-fold of the NLC and FB phosphate solution (FB-sol; p < 0.05), respectively. Precorneal retention assessed by gamma scintigraphy in vivo showed that the area under the remaining activity-time curve of the PDSC-coated formulation was 1.3-fold of the NLC and 2.4-fold of FB-sol. Moreover, in vivo ocular tolerance study indicated that there was no difference in irritation between the coated and noncoated NLC. In conclusion, novel NLC demonstrate high potential for ocular drug delivery.

摘要

本研究旨在提出一种新型的经部分脱乙酰化水溶性壳聚糖(NLC-PDSC)表面修饰的纳米结构脂质载体,作为一种有效的眼部给药系统,以提高其角膜透过性和角膜前滞留性。采用改良方法合成脱乙酰度约为 50%的 PDSC。采用熔融乳化法制备负载氟比洛芬(FB)的 NLC。透射电子显微镜和扫描电子显微镜下均呈现为球形形态。用 0.15%(w/v)PDSC 溶液包覆后,NLC 呈现核壳结构和反转的zeta 电位。采用离体兔角膜评估包衣 NLC 的增强角膜透过性,其表观渗透系数分别显著增加 1.40 倍和 1.75 倍,与 NLC 和 FB 磷酸盐溶液(FB-sol;p<0.05)相比。体内γ闪烁法评估角膜前滞留性显示,包衣制剂的剩余活性-时间曲线下面积分别是 NLC 的 1.3 倍和 FB-sol 的 2.4 倍。此外,体内眼耐受性研究表明,包衣和非包衣 NLC 之间的刺激性没有差异。综上所述,新型 NLC 具有很大的眼部药物传递潜力。

相似文献

[1]
Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.

J Pharm Sci. 2011-11-18

[2]
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.

Int J Pharm. 2010-10-15

[3]
Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.

Eur J Pharm Biopharm. 2017-9-1

[4]
A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.

Carbohydr Polym. 2016-3-29

[5]
Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.

Sci Rep. 2016-6-28

[6]
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.

J Pharm Sci. 2012-7-5

[7]
Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.

Mol Pharm. 2017-8-7

[8]
The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.

Colloids Surf B Biointerfaces. 2016-3-22

[9]
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions.

Int J Nanomedicine. 2014-9-11

[10]
Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.

Eur J Pharm Biopharm. 2016-12

引用本文的文献

[1]
Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery.

ACS Omega. 2022-12-20

[2]
Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.

Front Chem. 2022-4-13

[3]
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies.

Saudi Pharm J. 2021-9

[4]
Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model.

Int J Nanomedicine. 2021

[5]
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.

Pharmaceutics. 2020-3-23

[6]
Nanoparticles for drug delivery to the anterior segment of the eye.

Adv Drug Deliv Rev. 2017-4-6

[7]
CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.

Oncotarget. 2016-11-8

[8]
Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.

Sci Rep. 2016-6-28

[9]
Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.

J Biomed Nanotechnol. 2015-9

[10]
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions.

Int J Nanomedicine. 2014-9-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索